PeptideTrace
Clinical

New clinical trial registered for MOTS-c

Related compound: MOTS-cView source →

MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity (NCT07505745) registered on ClinicalTrials.gov. Phase: phase 2. Status: recruiting.